JDVFX | VIVIX | JDVFX / VIVIX | |
Total Expense Ratio | 0.85 | 0.04 | 2,125% |
Annual Report Gross Expense Ratio | 0.96 | 0.04 | 2,400% |
Fund Existence | 16 years | 27 years | - |
Gain YTD | -0.401 | -0.669 | 60% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.8B | 184B | 9% |
Annual Yield % from dividends | 0.88 | 2.35 | 37% |
Returns for 1 year | -7.67 | 4.59 | -167% |
Returns for 3 years | 3.33 | 21.42 | 16% |
Returns for 5 years | 39.85 | 72.66 | 55% |
Returns for 10 years | 23.26 | 97.34 | 24% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PMAY | 36.18 | 0.05 | +0.12% |
Innovator U.S. Equity Power BffrETF™-May | |||
SPHD | 47.35 | -0.02 | -0.04% |
Invesco S&P 500® High Div Low Vol ETF | |||
FLRG | 33.45 | -0.06 | -0.18% |
Fidelity U.S. Multifactor ETF | |||
TARK | 31.09 | -0.26 | -0.83% |
Tradr 2X Long Innovation ETF | |||
HELX | 25.66 | -0.47 | -1.81% |
Franklin Genomic Advancements ETF |